Global ATP Assay Market
Global ATP Assay Market

ATP Assay Comprehensive Study by Type (Consumables & Accessories {Reagents & Kits, Microplates, Other Consumables & Accessories}, Instruments {Luminometers, Spectrophotometers}), Application (Contamination Testing, Disease Testing, Drug Discovery & Development), End User (Pharmaceutical & Biotechnology Companies, Food & Beverage Industry, Hospitals & Diagnostics Laboratories, Academic & Research Institutions) Players and Region - Global Market Outlook to 2024

ATP Assay Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Nov 2019 Edition 209 Pages 211 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Scope of the Study

Adenosine 5'-triphosphate is defined as the cellular metabolism's chemical energy and is often related to as the cell's energy currency. During photosynthesis and cellular respiration, Adenosine 5'-triphosphate is obtained in living cells & absorbed in cellular processes, which include biosynthetic reactions, motility, cell division, and others. ATP Assay Kit offers a fast method for intracellular ATP measurement. The intensity of light is a direct measure of the concentration of intracellular Adenosine 5'-triphosphate. Adenosine 5'-triphosphate Assay Kit is intended as an easy method that uses glycerol phosphorylation to produce a product that is easily quantified by colorimetric.

The market study is being classified by Type (Consumables & Accessories {Reagents & Kits, Microplates, Other Consumables & Accessories} and Instruments {Luminometers, Spectrophotometers}), by Application (Contamination Testing, Disease Testing and Drug Discovery & Development) and major geographies with country level break-up.

Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (United States), Abcam plc. (United Kingdom), Danaher Corporation (United States), Hygiena, LLC. (United States), BioThema AB (Sweden), PerkinElmer, Inc. (United States), Lonza Group (Switzerland), Promega Corporation (United States) and Agilent Technologies, Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Abnova Corporation (Taiwan), AAT Bioquest (United States), PromoCell GmbH (Germany), BioVision, Inc. (United States), Geno Technology, Inc. (United States), Biotium (United States), Canvax Biotech S.L. (Spain), Creative Bioarray (United States), Elabscience (United States) and MBL International Corporation (United States).

Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global ATP Assay market throughout the predicted period.

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global ATP Assay market by Type, Application and Region.

On the basis of geography, the market of ATP Assay has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increasing Demand in Pharmaceutical and Biotech Companies for ATP Assay
  • Growing Prevalence of Cancer and Other Chronic as well as Infectious Diseases
  • Increasing Shift from Culture-Based Tests to Rapid Tests

Market Trend
  • Technology Advancement regarding ATP Assay

Restraints
  • Issue related to High Cost of Instruments

Opportunities
  • Growing Demand from Emerging Economics such as China, India and Others

Challenges
  • Lack of Awareness in Some region


Market Leaders and their expansionary development strategies
In August 2018, the Hygiena Company has acquired Biomedalís Food Safety division. Hence, this acquisition will strengthen the company presence in the ATP assay market across the globe.
In March 2019, the Promega Company has launched the Water-Glo reagent, which uses bioluminescent technology to measure Adenosine 5'-triphosphate. Hence, this launched will increase the product portfolio of the company.


Key Target Audience
ATP Assay Manufacturers Company, Regulatory Bodies, Component Suppliers, Government Regulatory Authorities, Technology Investors and Others

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Consumables & Accessories {Reagents & Kits, Microplates, Other Consumables & Accessories}
  • Instruments {Luminometers, Spectrophotometers}
By Application
  • Contamination Testing
  • Disease Testing
  • Drug Discovery & Development
By End User
  • Pharmaceutical & Biotechnology Companies
  • Food & Beverage Industry
  • Hospitals & Diagnostics Laboratories
  • Academic & Research Institutions

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Demand in Pharmaceutical and Biotech Companies for ATP Assay
      • 3.2.2. Growing Prevalence of Cancer and Other Chronic as well as Infectious Diseases
      • 3.2.3. Increasing Shift from Culture-Based Tests to Rapid Tests
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness in Some region
    • 3.4. Market Trends
      • 3.4.1. Technology Advancement regarding ATP Assay
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global ATP Assay, by Type, Application, End User and Region (value, volume and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global ATP Assay (Value)
      • 5.2.1. Global ATP Assay by: Type (Value)
        • 5.2.1.1. Consumables & Accessories {Reagents & Kits, Microplates, Other Consumables & Accessories}
        • 5.2.1.2. Instruments {Luminometers, Spectrophotometers}
      • 5.2.2. Global ATP Assay by: Application (Value)
        • 5.2.2.1. Contamination Testing
        • 5.2.2.2. Disease Testing
        • 5.2.2.3. Drug Discovery & Development
      • 5.2.3. Global ATP Assay by: End User (Value)
        • 5.2.3.1. Pharmaceutical & Biotechnology Companies
        • 5.2.3.2. Food & Beverage Industry
        • 5.2.3.3. Hospitals & Diagnostics Laboratories
        • 5.2.3.4. Academic & Research Institutions
      • 5.2.4. Global ATP Assay Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global ATP Assay (Volume)
      • 5.3.1. Global ATP Assay by: Type (Volume)
        • 5.3.1.1. Consumables & Accessories {Reagents & Kits, Microplates, Other Consumables & Accessories}
        • 5.3.1.2. Instruments {Luminometers, Spectrophotometers}
      • 5.3.2. Global ATP Assay by: Application (Volume)
        • 5.3.2.1. Contamination Testing
        • 5.3.2.2. Disease Testing
        • 5.3.2.3. Drug Discovery & Development
      • 5.3.3. Global ATP Assay by: End User (Volume)
        • 5.3.3.1. Pharmaceutical & Biotechnology Companies
        • 5.3.3.2. Food & Beverage Industry
        • 5.3.3.3. Hospitals & Diagnostics Laboratories
        • 5.3.3.4. Academic & Research Institutions
      • 5.3.4. Global ATP Assay Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global ATP Assay (Price)
      • 5.4.1. Global ATP Assay by: Type (Price)
  • 6. ATP Assay: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Merck KGaA (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Thermo Fisher Scientific, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Abcam plc. (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Danaher Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Hygiena, LLC. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. BioThema AB (Sweden)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. PerkinElmer, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Lonza Group (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Promega Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Agilent Technologies, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global ATP Assay Sale, by Type, Application, End User and Region (value, volume and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global ATP Assay (Value)
      • 7.2.1. Global ATP Assay by: Type (Value)
        • 7.2.1.1. Consumables & Accessories {Reagents & Kits, Microplates, Other Consumables & Accessories}
        • 7.2.1.2. Instruments {Luminometers, Spectrophotometers}
      • 7.2.2. Global ATP Assay by: Application (Value)
        • 7.2.2.1. Contamination Testing
        • 7.2.2.2. Disease Testing
        • 7.2.2.3. Drug Discovery & Development
      • 7.2.3. Global ATP Assay by: End User (Value)
        • 7.2.3.1. Pharmaceutical & Biotechnology Companies
        • 7.2.3.2. Food & Beverage Industry
        • 7.2.3.3. Hospitals & Diagnostics Laboratories
        • 7.2.3.4. Academic & Research Institutions
      • 7.2.4. Global ATP Assay Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global ATP Assay (Volume)
      • 7.3.1. Global ATP Assay by: Type (Volume)
        • 7.3.1.1. Consumables & Accessories {Reagents & Kits, Microplates, Other Consumables & Accessories}
        • 7.3.1.2. Instruments {Luminometers, Spectrophotometers}
      • 7.3.2. Global ATP Assay by: Application (Volume)
        • 7.3.2.1. Contamination Testing
        • 7.3.2.2. Disease Testing
        • 7.3.2.3. Drug Discovery & Development
      • 7.3.3. Global ATP Assay by: End User (Volume)
        • 7.3.3.1. Pharmaceutical & Biotechnology Companies
        • 7.3.3.2. Food & Beverage Industry
        • 7.3.3.3. Hospitals & Diagnostics Laboratories
        • 7.3.3.4. Academic & Research Institutions
      • 7.3.4. Global ATP Assay Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global ATP Assay (Price)
      • 7.4.1. Global ATP Assay by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. ATP Assay: by Type(USD Million)
  • Table 2. ATP Assay Consumables & Accessories {Reagents & Kits, Microplates, Other Consumables & Accessories} , by Region USD Million (2013-2018)
  • Table 3. ATP Assay Instruments {Luminometers, Spectrophotometers} , by Region USD Million (2013-2018)
  • Table 4. ATP Assay: by Application(USD Million)
  • Table 5. ATP Assay Contamination Testing , by Region USD Million (2013-2018)
  • Table 6. ATP Assay Disease Testing , by Region USD Million (2013-2018)
  • Table 7. ATP Assay Drug Discovery & Development , by Region USD Million (2013-2018)
  • Table 8. ATP Assay: by End User(USD Million)
  • Table 9. ATP Assay Pharmaceutical & Biotechnology Companies , by Region USD Million (2013-2018)
  • Table 10. ATP Assay Food & Beverage Industry , by Region USD Million (2013-2018)
  • Table 11. ATP Assay Hospitals & Diagnostics Laboratories , by Region USD Million (2013-2018)
  • Table 12. ATP Assay Academic & Research Institutions , by Region USD Million (2013-2018)
  • Table 13. South America ATP Assay, by Country USD Million (2013-2018)
  • Table 14. South America ATP Assay, by Type USD Million (2013-2018)
  • Table 15. South America ATP Assay, by Application USD Million (2013-2018)
  • Table 16. South America ATP Assay, by End User USD Million (2013-2018)
  • Table 17. Brazil ATP Assay, by Type USD Million (2013-2018)
  • Table 18. Brazil ATP Assay, by Application USD Million (2013-2018)
  • Table 19. Brazil ATP Assay, by End User USD Million (2013-2018)
  • Table 20. Argentina ATP Assay, by Type USD Million (2013-2018)
  • Table 21. Argentina ATP Assay, by Application USD Million (2013-2018)
  • Table 22. Argentina ATP Assay, by End User USD Million (2013-2018)
  • Table 23. Rest of South America ATP Assay, by Type USD Million (2013-2018)
  • Table 24. Rest of South America ATP Assay, by Application USD Million (2013-2018)
  • Table 25. Rest of South America ATP Assay, by End User USD Million (2013-2018)
  • Table 26. Asia Pacific ATP Assay, by Country USD Million (2013-2018)
  • Table 27. Asia Pacific ATP Assay, by Type USD Million (2013-2018)
  • Table 28. Asia Pacific ATP Assay, by Application USD Million (2013-2018)
  • Table 29. Asia Pacific ATP Assay, by End User USD Million (2013-2018)
  • Table 30. China ATP Assay, by Type USD Million (2013-2018)
  • Table 31. China ATP Assay, by Application USD Million (2013-2018)
  • Table 32. China ATP Assay, by End User USD Million (2013-2018)
  • Table 33. Japan ATP Assay, by Type USD Million (2013-2018)
  • Table 34. Japan ATP Assay, by Application USD Million (2013-2018)
  • Table 35. Japan ATP Assay, by End User USD Million (2013-2018)
  • Table 36. India ATP Assay, by Type USD Million (2013-2018)
  • Table 37. India ATP Assay, by Application USD Million (2013-2018)
  • Table 38. India ATP Assay, by End User USD Million (2013-2018)
  • Table 39. South Korea ATP Assay, by Type USD Million (2013-2018)
  • Table 40. South Korea ATP Assay, by Application USD Million (2013-2018)
  • Table 41. South Korea ATP Assay, by End User USD Million (2013-2018)
  • Table 42. Taiwan ATP Assay, by Type USD Million (2013-2018)
  • Table 43. Taiwan ATP Assay, by Application USD Million (2013-2018)
  • Table 44. Taiwan ATP Assay, by End User USD Million (2013-2018)
  • Table 45. Australia ATP Assay, by Type USD Million (2013-2018)
  • Table 46. Australia ATP Assay, by Application USD Million (2013-2018)
  • Table 47. Australia ATP Assay, by End User USD Million (2013-2018)
  • Table 48. Rest of Asia-Pacific ATP Assay, by Type USD Million (2013-2018)
  • Table 49. Rest of Asia-Pacific ATP Assay, by Application USD Million (2013-2018)
  • Table 50. Rest of Asia-Pacific ATP Assay, by End User USD Million (2013-2018)
  • Table 51. Europe ATP Assay, by Country USD Million (2013-2018)
  • Table 52. Europe ATP Assay, by Type USD Million (2013-2018)
  • Table 53. Europe ATP Assay, by Application USD Million (2013-2018)
  • Table 54. Europe ATP Assay, by End User USD Million (2013-2018)
  • Table 55. Germany ATP Assay, by Type USD Million (2013-2018)
  • Table 56. Germany ATP Assay, by Application USD Million (2013-2018)
  • Table 57. Germany ATP Assay, by End User USD Million (2013-2018)
  • Table 58. France ATP Assay, by Type USD Million (2013-2018)
  • Table 59. France ATP Assay, by Application USD Million (2013-2018)
  • Table 60. France ATP Assay, by End User USD Million (2013-2018)
  • Table 61. Italy ATP Assay, by Type USD Million (2013-2018)
  • Table 62. Italy ATP Assay, by Application USD Million (2013-2018)
  • Table 63. Italy ATP Assay, by End User USD Million (2013-2018)
  • Table 64. United Kingdom ATP Assay, by Type USD Million (2013-2018)
  • Table 65. United Kingdom ATP Assay, by Application USD Million (2013-2018)
  • Table 66. United Kingdom ATP Assay, by End User USD Million (2013-2018)
  • Table 67. Netherlands ATP Assay, by Type USD Million (2013-2018)
  • Table 68. Netherlands ATP Assay, by Application USD Million (2013-2018)
  • Table 69. Netherlands ATP Assay, by End User USD Million (2013-2018)
  • Table 70. Rest of Europe ATP Assay, by Type USD Million (2013-2018)
  • Table 71. Rest of Europe ATP Assay, by Application USD Million (2013-2018)
  • Table 72. Rest of Europe ATP Assay, by End User USD Million (2013-2018)
  • Table 73. MEA ATP Assay, by Country USD Million (2013-2018)
  • Table 74. MEA ATP Assay, by Type USD Million (2013-2018)
  • Table 75. MEA ATP Assay, by Application USD Million (2013-2018)
  • Table 76. MEA ATP Assay, by End User USD Million (2013-2018)
  • Table 77. Middle East ATP Assay, by Type USD Million (2013-2018)
  • Table 78. Middle East ATP Assay, by Application USD Million (2013-2018)
  • Table 79. Middle East ATP Assay, by End User USD Million (2013-2018)
  • Table 80. Africa ATP Assay, by Type USD Million (2013-2018)
  • Table 81. Africa ATP Assay, by Application USD Million (2013-2018)
  • Table 82. Africa ATP Assay, by End User USD Million (2013-2018)
  • Table 83. North America ATP Assay, by Country USD Million (2013-2018)
  • Table 84. North America ATP Assay, by Type USD Million (2013-2018)
  • Table 85. North America ATP Assay, by Application USD Million (2013-2018)
  • Table 86. North America ATP Assay, by End User USD Million (2013-2018)
  • Table 87. United States ATP Assay, by Type USD Million (2013-2018)
  • Table 88. United States ATP Assay, by Application USD Million (2013-2018)
  • Table 89. United States ATP Assay, by End User USD Million (2013-2018)
  • Table 90. Canada ATP Assay, by Type USD Million (2013-2018)
  • Table 91. Canada ATP Assay, by Application USD Million (2013-2018)
  • Table 92. Canada ATP Assay, by End User USD Million (2013-2018)
  • Table 93. Mexico ATP Assay, by Type USD Million (2013-2018)
  • Table 94. Mexico ATP Assay, by Application USD Million (2013-2018)
  • Table 95. Mexico ATP Assay, by End User USD Million (2013-2018)
  • Table 96. ATP Assay Sales: by Type(M Units)
  • Table 97. ATP Assay Sales Consumables & Accessories {Reagents & Kits, Microplates, Other Consumables & Accessories} , by Region M Units (2013-2018)
  • Table 98. ATP Assay Sales Instruments {Luminometers, Spectrophotometers} , by Region M Units (2013-2018)
  • Table 99. ATP Assay Sales: by Application(M Units)
  • Table 100. ATP Assay Sales Contamination Testing , by Region M Units (2013-2018)
  • Table 101. ATP Assay Sales Disease Testing , by Region M Units (2013-2018)
  • Table 102. ATP Assay Sales Drug Discovery & Development , by Region M Units (2013-2018)
  • Table 103. ATP Assay Sales: by End User(M Units)
  • Table 104. ATP Assay Sales Pharmaceutical & Biotechnology Companies , by Region M Units (2013-2018)
  • Table 105. ATP Assay Sales Food & Beverage Industry , by Region M Units (2013-2018)
  • Table 106. ATP Assay Sales Hospitals & Diagnostics Laboratories , by Region M Units (2013-2018)
  • Table 107. ATP Assay Sales Academic & Research Institutions , by Region M Units (2013-2018)
  • Table 108. South America ATP Assay Sales, by Country M Units (2013-2018)
  • Table 109. South America ATP Assay Sales, by Type M Units (2013-2018)
  • Table 110. South America ATP Assay Sales, by Application M Units (2013-2018)
  • Table 111. South America ATP Assay Sales, by End User M Units (2013-2018)
  • Table 112. Brazil ATP Assay Sales, by Type M Units (2013-2018)
  • Table 113. Brazil ATP Assay Sales, by Application M Units (2013-2018)
  • Table 114. Brazil ATP Assay Sales, by End User M Units (2013-2018)
  • Table 115. Argentina ATP Assay Sales, by Type M Units (2013-2018)
  • Table 116. Argentina ATP Assay Sales, by Application M Units (2013-2018)
  • Table 117. Argentina ATP Assay Sales, by End User M Units (2013-2018)
  • Table 118. Rest of South America ATP Assay Sales, by Type M Units (2013-2018)
  • Table 119. Rest of South America ATP Assay Sales, by Application M Units (2013-2018)
  • Table 120. Rest of South America ATP Assay Sales, by End User M Units (2013-2018)
  • Table 121. Asia Pacific ATP Assay Sales, by Country M Units (2013-2018)
  • Table 122. Asia Pacific ATP Assay Sales, by Type M Units (2013-2018)
  • Table 123. Asia Pacific ATP Assay Sales, by Application M Units (2013-2018)
  • Table 124. Asia Pacific ATP Assay Sales, by End User M Units (2013-2018)
  • Table 125. China ATP Assay Sales, by Type M Units (2013-2018)
  • Table 126. China ATP Assay Sales, by Application M Units (2013-2018)
  • Table 127. China ATP Assay Sales, by End User M Units (2013-2018)
  • Table 128. Japan ATP Assay Sales, by Type M Units (2013-2018)
  • Table 129. Japan ATP Assay Sales, by Application M Units (2013-2018)
  • Table 130. Japan ATP Assay Sales, by End User M Units (2013-2018)
  • Table 131. India ATP Assay Sales, by Type M Units (2013-2018)
  • Table 132. India ATP Assay Sales, by Application M Units (2013-2018)
  • Table 133. India ATP Assay Sales, by End User M Units (2013-2018)
  • Table 134. South Korea ATP Assay Sales, by Type M Units (2013-2018)
  • Table 135. South Korea ATP Assay Sales, by Application M Units (2013-2018)
  • Table 136. South Korea ATP Assay Sales, by End User M Units (2013-2018)
  • Table 137. Taiwan ATP Assay Sales, by Type M Units (2013-2018)
  • Table 138. Taiwan ATP Assay Sales, by Application M Units (2013-2018)
  • Table 139. Taiwan ATP Assay Sales, by End User M Units (2013-2018)
  • Table 140. Australia ATP Assay Sales, by Type M Units (2013-2018)
  • Table 141. Australia ATP Assay Sales, by Application M Units (2013-2018)
  • Table 142. Australia ATP Assay Sales, by End User M Units (2013-2018)
  • Table 143. Rest of Asia-Pacific ATP Assay Sales, by Type M Units (2013-2018)
  • Table 144. Rest of Asia-Pacific ATP Assay Sales, by Application M Units (2013-2018)
  • Table 145. Rest of Asia-Pacific ATP Assay Sales, by End User M Units (2013-2018)
  • Table 146. Europe ATP Assay Sales, by Country M Units (2013-2018)
  • Table 147. Europe ATP Assay Sales, by Type M Units (2013-2018)
  • Table 148. Europe ATP Assay Sales, by Application M Units (2013-2018)
  • Table 149. Europe ATP Assay Sales, by End User M Units (2013-2018)
  • Table 150. Germany ATP Assay Sales, by Type M Units (2013-2018)
  • Table 151. Germany ATP Assay Sales, by Application M Units (2013-2018)
  • Table 152. Germany ATP Assay Sales, by End User M Units (2013-2018)
  • Table 153. France ATP Assay Sales, by Type M Units (2013-2018)
  • Table 154. France ATP Assay Sales, by Application M Units (2013-2018)
  • Table 155. France ATP Assay Sales, by End User M Units (2013-2018)
  • Table 156. Italy ATP Assay Sales, by Type M Units (2013-2018)
  • Table 157. Italy ATP Assay Sales, by Application M Units (2013-2018)
  • Table 158. Italy ATP Assay Sales, by End User M Units (2013-2018)
  • Table 159. United Kingdom ATP Assay Sales, by Type M Units (2013-2018)
  • Table 160. United Kingdom ATP Assay Sales, by Application M Units (2013-2018)
  • Table 161. United Kingdom ATP Assay Sales, by End User M Units (2013-2018)
  • Table 162. Netherlands ATP Assay Sales, by Type M Units (2013-2018)
  • Table 163. Netherlands ATP Assay Sales, by Application M Units (2013-2018)
  • Table 164. Netherlands ATP Assay Sales, by End User M Units (2013-2018)
  • Table 165. Rest of Europe ATP Assay Sales, by Type M Units (2013-2018)
  • Table 166. Rest of Europe ATP Assay Sales, by Application M Units (2013-2018)
  • Table 167. Rest of Europe ATP Assay Sales, by End User M Units (2013-2018)
  • Table 168. MEA ATP Assay Sales, by Country M Units (2013-2018)
  • Table 169. MEA ATP Assay Sales, by Type M Units (2013-2018)
  • Table 170. MEA ATP Assay Sales, by Application M Units (2013-2018)
  • Table 171. MEA ATP Assay Sales, by End User M Units (2013-2018)
  • Table 172. Middle East ATP Assay Sales, by Type M Units (2013-2018)
  • Table 173. Middle East ATP Assay Sales, by Application M Units (2013-2018)
  • Table 174. Middle East ATP Assay Sales, by End User M Units (2013-2018)
  • Table 175. Africa ATP Assay Sales, by Type M Units (2013-2018)
  • Table 176. Africa ATP Assay Sales, by Application M Units (2013-2018)
  • Table 177. Africa ATP Assay Sales, by End User M Units (2013-2018)
  • Table 178. North America ATP Assay Sales, by Country M Units (2013-2018)
  • Table 179. North America ATP Assay Sales, by Type M Units (2013-2018)
  • Table 180. North America ATP Assay Sales, by Application M Units (2013-2018)
  • Table 181. North America ATP Assay Sales, by End User M Units (2013-2018)
  • Table 182. United States ATP Assay Sales, by Type M Units (2013-2018)
  • Table 183. United States ATP Assay Sales, by Application M Units (2013-2018)
  • Table 184. United States ATP Assay Sales, by End User M Units (2013-2018)
  • Table 185. Canada ATP Assay Sales, by Type M Units (2013-2018)
  • Table 186. Canada ATP Assay Sales, by Application M Units (2013-2018)
  • Table 187. Canada ATP Assay Sales, by End User M Units (2013-2018)
  • Table 188. Mexico ATP Assay Sales, by Type M Units (2013-2018)
  • Table 189. Mexico ATP Assay Sales, by Application M Units (2013-2018)
  • Table 190. Mexico ATP Assay Sales, by End User M Units (2013-2018)
  • Table 191. ATP Assay: by Type(USD/Units)
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. ATP Assay: by Type(USD Million)
  • Table 203. ATP Assay Consumables & Accessories {Reagents & Kits, Microplates, Other Consumables & Accessories} , by Region USD Million (2019-2024)
  • Table 204. ATP Assay Instruments {Luminometers, Spectrophotometers} , by Region USD Million (2019-2024)
  • Table 205. ATP Assay: by Application(USD Million)
  • Table 206. ATP Assay Contamination Testing , by Region USD Million (2019-2024)
  • Table 207. ATP Assay Disease Testing , by Region USD Million (2019-2024)
  • Table 208. ATP Assay Drug Discovery & Development , by Region USD Million (2019-2024)
  • Table 209. ATP Assay: by End User(USD Million)
  • Table 210. ATP Assay Pharmaceutical & Biotechnology Companies , by Region USD Million (2019-2024)
  • Table 211. ATP Assay Food & Beverage Industry , by Region USD Million (2019-2024)
  • Table 212. ATP Assay Hospitals & Diagnostics Laboratories , by Region USD Million (2019-2024)
  • Table 213. ATP Assay Academic & Research Institutions , by Region USD Million (2019-2024)
  • Table 214. South America ATP Assay, by Country USD Million (2019-2024)
  • Table 215. South America ATP Assay, by Type USD Million (2019-2024)
  • Table 216. South America ATP Assay, by Application USD Million (2019-2024)
  • Table 217. South America ATP Assay, by End User USD Million (2019-2024)
  • Table 218. Brazil ATP Assay, by Type USD Million (2019-2024)
  • Table 219. Brazil ATP Assay, by Application USD Million (2019-2024)
  • Table 220. Brazil ATP Assay, by End User USD Million (2019-2024)
  • Table 221. Argentina ATP Assay, by Type USD Million (2019-2024)
  • Table 222. Argentina ATP Assay, by Application USD Million (2019-2024)
  • Table 223. Argentina ATP Assay, by End User USD Million (2019-2024)
  • Table 224. Rest of South America ATP Assay, by Type USD Million (2019-2024)
  • Table 225. Rest of South America ATP Assay, by Application USD Million (2019-2024)
  • Table 226. Rest of South America ATP Assay, by End User USD Million (2019-2024)
  • Table 227. Asia Pacific ATP Assay, by Country USD Million (2019-2024)
  • Table 228. Asia Pacific ATP Assay, by Type USD Million (2019-2024)
  • Table 229. Asia Pacific ATP Assay, by Application USD Million (2019-2024)
  • Table 230. Asia Pacific ATP Assay, by End User USD Million (2019-2024)
  • Table 231. China ATP Assay, by Type USD Million (2019-2024)
  • Table 232. China ATP Assay, by Application USD Million (2019-2024)
  • Table 233. China ATP Assay, by End User USD Million (2019-2024)
  • Table 234. Japan ATP Assay, by Type USD Million (2019-2024)
  • Table 235. Japan ATP Assay, by Application USD Million (2019-2024)
  • Table 236. Japan ATP Assay, by End User USD Million (2019-2024)
  • Table 237. India ATP Assay, by Type USD Million (2019-2024)
  • Table 238. India ATP Assay, by Application USD Million (2019-2024)
  • Table 239. India ATP Assay, by End User USD Million (2019-2024)
  • Table 240. South Korea ATP Assay, by Type USD Million (2019-2024)
  • Table 241. South Korea ATP Assay, by Application USD Million (2019-2024)
  • Table 242. South Korea ATP Assay, by End User USD Million (2019-2024)
  • Table 243. Taiwan ATP Assay, by Type USD Million (2019-2024)
  • Table 244. Taiwan ATP Assay, by Application USD Million (2019-2024)
  • Table 245. Taiwan ATP Assay, by End User USD Million (2019-2024)
  • Table 246. Australia ATP Assay, by Type USD Million (2019-2024)
  • Table 247. Australia ATP Assay, by Application USD Million (2019-2024)
  • Table 248. Australia ATP Assay, by End User USD Million (2019-2024)
  • Table 249. Rest of Asia-Pacific ATP Assay, by Type USD Million (2019-2024)
  • Table 250. Rest of Asia-Pacific ATP Assay, by Application USD Million (2019-2024)
  • Table 251. Rest of Asia-Pacific ATP Assay, by End User USD Million (2019-2024)
  • Table 252. Europe ATP Assay, by Country USD Million (2019-2024)
  • Table 253. Europe ATP Assay, by Type USD Million (2019-2024)
  • Table 254. Europe ATP Assay, by Application USD Million (2019-2024)
  • Table 255. Europe ATP Assay, by End User USD Million (2019-2024)
  • Table 256. Germany ATP Assay, by Type USD Million (2019-2024)
  • Table 257. Germany ATP Assay, by Application USD Million (2019-2024)
  • Table 258. Germany ATP Assay, by End User USD Million (2019-2024)
  • Table 259. France ATP Assay, by Type USD Million (2019-2024)
  • Table 260. France ATP Assay, by Application USD Million (2019-2024)
  • Table 261. France ATP Assay, by End User USD Million (2019-2024)
  • Table 262. Italy ATP Assay, by Type USD Million (2019-2024)
  • Table 263. Italy ATP Assay, by Application USD Million (2019-2024)
  • Table 264. Italy ATP Assay, by End User USD Million (2019-2024)
  • Table 265. United Kingdom ATP Assay, by Type USD Million (2019-2024)
  • Table 266. United Kingdom ATP Assay, by Application USD Million (2019-2024)
  • Table 267. United Kingdom ATP Assay, by End User USD Million (2019-2024)
  • Table 268. Netherlands ATP Assay, by Type USD Million (2019-2024)
  • Table 269. Netherlands ATP Assay, by Application USD Million (2019-2024)
  • Table 270. Netherlands ATP Assay, by End User USD Million (2019-2024)
  • Table 271. Rest of Europe ATP Assay, by Type USD Million (2019-2024)
  • Table 272. Rest of Europe ATP Assay, by Application USD Million (2019-2024)
  • Table 273. Rest of Europe ATP Assay, by End User USD Million (2019-2024)
  • Table 274. MEA ATP Assay, by Country USD Million (2019-2024)
  • Table 275. MEA ATP Assay, by Type USD Million (2019-2024)
  • Table 276. MEA ATP Assay, by Application USD Million (2019-2024)
  • Table 277. MEA ATP Assay, by End User USD Million (2019-2024)
  • Table 278. Middle East ATP Assay, by Type USD Million (2019-2024)
  • Table 279. Middle East ATP Assay, by Application USD Million (2019-2024)
  • Table 280. Middle East ATP Assay, by End User USD Million (2019-2024)
  • Table 281. Africa ATP Assay, by Type USD Million (2019-2024)
  • Table 282. Africa ATP Assay, by Application USD Million (2019-2024)
  • Table 283. Africa ATP Assay, by End User USD Million (2019-2024)
  • Table 284. North America ATP Assay, by Country USD Million (2019-2024)
  • Table 285. North America ATP Assay, by Type USD Million (2019-2024)
  • Table 286. North America ATP Assay, by Application USD Million (2019-2024)
  • Table 287. North America ATP Assay, by End User USD Million (2019-2024)
  • Table 288. United States ATP Assay, by Type USD Million (2019-2024)
  • Table 289. United States ATP Assay, by Application USD Million (2019-2024)
  • Table 290. United States ATP Assay, by End User USD Million (2019-2024)
  • Table 291. Canada ATP Assay, by Type USD Million (2019-2024)
  • Table 292. Canada ATP Assay, by Application USD Million (2019-2024)
  • Table 293. Canada ATP Assay, by End User USD Million (2019-2024)
  • Table 294. Mexico ATP Assay, by Type USD Million (2019-2024)
  • Table 295. Mexico ATP Assay, by Application USD Million (2019-2024)
  • Table 296. Mexico ATP Assay, by End User USD Million (2019-2024)
  • Table 297. ATP Assay Sales: by Type(M Units)
  • Table 298. ATP Assay Sales Consumables & Accessories {Reagents & Kits, Microplates, Other Consumables & Accessories} , by Region M Units (2019-2024)
  • Table 299. ATP Assay Sales Instruments {Luminometers, Spectrophotometers} , by Region M Units (2019-2024)
  • Table 300. ATP Assay Sales: by Application(M Units)
  • Table 301. ATP Assay Sales Contamination Testing , by Region M Units (2019-2024)
  • Table 302. ATP Assay Sales Disease Testing , by Region M Units (2019-2024)
  • Table 303. ATP Assay Sales Drug Discovery & Development , by Region M Units (2019-2024)
  • Table 304. ATP Assay Sales: by End User(M Units)
  • Table 305. ATP Assay Sales Pharmaceutical & Biotechnology Companies , by Region M Units (2019-2024)
  • Table 306. ATP Assay Sales Food & Beverage Industry , by Region M Units (2019-2024)
  • Table 307. ATP Assay Sales Hospitals & Diagnostics Laboratories , by Region M Units (2019-2024)
  • Table 308. ATP Assay Sales Academic & Research Institutions , by Region M Units (2019-2024)
  • Table 309. South America ATP Assay Sales, by Country M Units (2019-2024)
  • Table 310. South America ATP Assay Sales, by Type M Units (2019-2024)
  • Table 311. South America ATP Assay Sales, by Application M Units (2019-2024)
  • Table 312. South America ATP Assay Sales, by End User M Units (2019-2024)
  • Table 313. Brazil ATP Assay Sales, by Type M Units (2019-2024)
  • Table 314. Brazil ATP Assay Sales, by Application M Units (2019-2024)
  • Table 315. Brazil ATP Assay Sales, by End User M Units (2019-2024)
  • Table 316. Argentina ATP Assay Sales, by Type M Units (2019-2024)
  • Table 317. Argentina ATP Assay Sales, by Application M Units (2019-2024)
  • Table 318. Argentina ATP Assay Sales, by End User M Units (2019-2024)
  • Table 319. Rest of South America ATP Assay Sales, by Type M Units (2019-2024)
  • Table 320. Rest of South America ATP Assay Sales, by Application M Units (2019-2024)
  • Table 321. Rest of South America ATP Assay Sales, by End User M Units (2019-2024)
  • Table 322. Asia Pacific ATP Assay Sales, by Country M Units (2019-2024)
  • Table 323. Asia Pacific ATP Assay Sales, by Type M Units (2019-2024)
  • Table 324. Asia Pacific ATP Assay Sales, by Application M Units (2019-2024)
  • Table 325. Asia Pacific ATP Assay Sales, by End User M Units (2019-2024)
  • Table 326. China ATP Assay Sales, by Type M Units (2019-2024)
  • Table 327. China ATP Assay Sales, by Application M Units (2019-2024)
  • Table 328. China ATP Assay Sales, by End User M Units (2019-2024)
  • Table 329. Japan ATP Assay Sales, by Type M Units (2019-2024)
  • Table 330. Japan ATP Assay Sales, by Application M Units (2019-2024)
  • Table 331. Japan ATP Assay Sales, by End User M Units (2019-2024)
  • Table 332. India ATP Assay Sales, by Type M Units (2019-2024)
  • Table 333. India ATP Assay Sales, by Application M Units (2019-2024)
  • Table 334. India ATP Assay Sales, by End User M Units (2019-2024)
  • Table 335. South Korea ATP Assay Sales, by Type M Units (2019-2024)
  • Table 336. South Korea ATP Assay Sales, by Application M Units (2019-2024)
  • Table 337. South Korea ATP Assay Sales, by End User M Units (2019-2024)
  • Table 338. Taiwan ATP Assay Sales, by Type M Units (2019-2024)
  • Table 339. Taiwan ATP Assay Sales, by Application M Units (2019-2024)
  • Table 340. Taiwan ATP Assay Sales, by End User M Units (2019-2024)
  • Table 341. Australia ATP Assay Sales, by Type M Units (2019-2024)
  • Table 342. Australia ATP Assay Sales, by Application M Units (2019-2024)
  • Table 343. Australia ATP Assay Sales, by End User M Units (2019-2024)
  • Table 344. Rest of Asia-Pacific ATP Assay Sales, by Type M Units (2019-2024)
  • Table 345. Rest of Asia-Pacific ATP Assay Sales, by Application M Units (2019-2024)
  • Table 346. Rest of Asia-Pacific ATP Assay Sales, by End User M Units (2019-2024)
  • Table 347. Europe ATP Assay Sales, by Country M Units (2019-2024)
  • Table 348. Europe ATP Assay Sales, by Type M Units (2019-2024)
  • Table 349. Europe ATP Assay Sales, by Application M Units (2019-2024)
  • Table 350. Europe ATP Assay Sales, by End User M Units (2019-2024)
  • Table 351. Germany ATP Assay Sales, by Type M Units (2019-2024)
  • Table 352. Germany ATP Assay Sales, by Application M Units (2019-2024)
  • Table 353. Germany ATP Assay Sales, by End User M Units (2019-2024)
  • Table 354. France ATP Assay Sales, by Type M Units (2019-2024)
  • Table 355. France ATP Assay Sales, by Application M Units (2019-2024)
  • Table 356. France ATP Assay Sales, by End User M Units (2019-2024)
  • Table 357. Italy ATP Assay Sales, by Type M Units (2019-2024)
  • Table 358. Italy ATP Assay Sales, by Application M Units (2019-2024)
  • Table 359. Italy ATP Assay Sales, by End User M Units (2019-2024)
  • Table 360. United Kingdom ATP Assay Sales, by Type M Units (2019-2024)
  • Table 361. United Kingdom ATP Assay Sales, by Application M Units (2019-2024)
  • Table 362. United Kingdom ATP Assay Sales, by End User M Units (2019-2024)
  • Table 363. Netherlands ATP Assay Sales, by Type M Units (2019-2024)
  • Table 364. Netherlands ATP Assay Sales, by Application M Units (2019-2024)
  • Table 365. Netherlands ATP Assay Sales, by End User M Units (2019-2024)
  • Table 366. Rest of Europe ATP Assay Sales, by Type M Units (2019-2024)
  • Table 367. Rest of Europe ATP Assay Sales, by Application M Units (2019-2024)
  • Table 368. Rest of Europe ATP Assay Sales, by End User M Units (2019-2024)
  • Table 369. MEA ATP Assay Sales, by Country M Units (2019-2024)
  • Table 370. MEA ATP Assay Sales, by Type M Units (2019-2024)
  • Table 371. MEA ATP Assay Sales, by Application M Units (2019-2024)
  • Table 372. MEA ATP Assay Sales, by End User M Units (2019-2024)
  • Table 373. Middle East ATP Assay Sales, by Type M Units (2019-2024)
  • Table 374. Middle East ATP Assay Sales, by Application M Units (2019-2024)
  • Table 375. Middle East ATP Assay Sales, by End User M Units (2019-2024)
  • Table 376. Africa ATP Assay Sales, by Type M Units (2019-2024)
  • Table 377. Africa ATP Assay Sales, by Application M Units (2019-2024)
  • Table 378. Africa ATP Assay Sales, by End User M Units (2019-2024)
  • Table 379. North America ATP Assay Sales, by Country M Units (2019-2024)
  • Table 380. North America ATP Assay Sales, by Type M Units (2019-2024)
  • Table 381. North America ATP Assay Sales, by Application M Units (2019-2024)
  • Table 382. North America ATP Assay Sales, by End User M Units (2019-2024)
  • Table 383. United States ATP Assay Sales, by Type M Units (2019-2024)
  • Table 384. United States ATP Assay Sales, by Application M Units (2019-2024)
  • Table 385. United States ATP Assay Sales, by End User M Units (2019-2024)
  • Table 386. Canada ATP Assay Sales, by Type M Units (2019-2024)
  • Table 387. Canada ATP Assay Sales, by Application M Units (2019-2024)
  • Table 388. Canada ATP Assay Sales, by End User M Units (2019-2024)
  • Table 389. Mexico ATP Assay Sales, by Type M Units (2019-2024)
  • Table 390. Mexico ATP Assay Sales, by Application M Units (2019-2024)
  • Table 391. Mexico ATP Assay Sales, by End User M Units (2019-2024)
  • Table 392. ATP Assay: by Type(USD/Units)
  • Table 393. Research Programs/Design for This Report
  • Table 394. Key Data Information from Secondary Sources
  • Table 395. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global ATP Assay: by Type USD Million (2013-2018)
  • Figure 5. Global ATP Assay: by Application USD Million (2013-2018)
  • Figure 6. Global ATP Assay: by End User USD Million (2013-2018)
  • Figure 7. South America ATP Assay Share (%), by Country
  • Figure 8. Asia Pacific ATP Assay Share (%), by Country
  • Figure 9. Europe ATP Assay Share (%), by Country
  • Figure 10. MEA ATP Assay Share (%), by Country
  • Figure 11. North America ATP Assay Share (%), by Country
  • Figure 12. Global ATP Assay: by Type M Units (2013-2018)
  • Figure 13. Global ATP Assay: by Application M Units (2013-2018)
  • Figure 14. Global ATP Assay: by End User M Units (2013-2018)
  • Figure 15. South America ATP Assay Share (%), by Country
  • Figure 16. Asia Pacific ATP Assay Share (%), by Country
  • Figure 17. Europe ATP Assay Share (%), by Country
  • Figure 18. MEA ATP Assay Share (%), by Country
  • Figure 19. North America ATP Assay Share (%), by Country
  • Figure 20. Global ATP Assay: by Type USD/Units (2013-2018)
  • Figure 21. Global ATP Assay share by Players 2018 (%)
  • Figure 22. Global ATP Assay share by Players (Top 3) 2018(%)
  • Figure 23. Global ATP Assay share by Players (Top 5) 2018(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 26. Merck KGaA (Germany) Revenue: by Geography 2018
  • Figure 27. Thermo Fisher Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Thermo Fisher Scientific, Inc. (United States) Revenue: by Geography 2018
  • Figure 29. Abcam plc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. Abcam plc. (United Kingdom) Revenue: by Geography 2018
  • Figure 31. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 32. Danaher Corporation (United States) Revenue: by Geography 2018
  • Figure 33. Hygiena, LLC. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Hygiena, LLC. (United States) Revenue: by Geography 2018
  • Figure 35. BioThema AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 36. BioThema AB (Sweden) Revenue: by Geography 2018
  • Figure 37. PerkinElmer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 38. PerkinElmer, Inc. (United States) Revenue: by Geography 2018
  • Figure 39. Lonza Group (Switzerland) Revenue, Net Income and Gross profit
  • Figure 40. Lonza Group (Switzerland) Revenue: by Geography 2018
  • Figure 41. Promega Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 42. Promega Corporation (United States) Revenue: by Geography 2018
  • Figure 43. Agilent Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 44. Agilent Technologies, Inc. (United States) Revenue: by Geography 2018
  • Figure 45. Global ATP Assay: by Type USD Million (2019-2024)
  • Figure 46. Global ATP Assay: by Application USD Million (2019-2024)
  • Figure 47. Global ATP Assay: by End User USD Million (2019-2024)
  • Figure 48. South America ATP Assay Share (%), by Country
  • Figure 49. Asia Pacific ATP Assay Share (%), by Country
  • Figure 50. Europe ATP Assay Share (%), by Country
  • Figure 51. MEA ATP Assay Share (%), by Country
  • Figure 52. North America ATP Assay Share (%), by Country
  • Figure 53. Global ATP Assay: by Type M Units (2019-2024)
  • Figure 54. Global ATP Assay: by Application M Units (2019-2024)
  • Figure 55. Global ATP Assay: by End User M Units (2019-2024)
  • Figure 56. South America ATP Assay Share (%), by Country
  • Figure 57. Asia Pacific ATP Assay Share (%), by Country
  • Figure 58. Europe ATP Assay Share (%), by Country
  • Figure 59. MEA ATP Assay Share (%), by Country
  • Figure 60. North America ATP Assay Share (%), by Country
  • Figure 61. Global ATP Assay: by Type USD/Units (2019-2024)
Some of the key companies/manufacturers profiled in the report
  • Merck KGaA (Germany)
  • Thermo Fisher Scientific, Inc. (United States)
  • Abcam plc. (United Kingdom)
  • Danaher Corporation (United States)
  • Hygiena, LLC. (United States)
  • BioThema AB (Sweden)
  • PerkinElmer, Inc. (United States)
  • Lonza Group (Switzerland)
  • Promega Corporation (United States)
  • Agilent Technologies, Inc. (United States)
Additional players considered in the study are as follows:
Abnova Corporation (Taiwan) , AAT Bioquest (United States) , PromoCell GmbH (Germany) , BioVision, Inc. (United States) , Geno Technology, Inc. (United States) , Biotium (United States) , Canvax Biotech S.L. (Spain) , Creative Bioarray (United States) , Elabscience (United States) , MBL International Corporation (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation